Sentence examples for invalid companies from inspiring English sources

By 1771, there were 32 companies of the Royal Artillery in four battalions, as well as two Invalid Companies comprising older and unfit men employed in garrison duties.

On the other side are Myriad and industry groups such as the Biotechnology Industry Organization (BIO) and the Animal Health Institute, which say that if gene patenting is ruled invalid, companies - with no guarantee they could profit from their discoveries - would stop investing in genetics research, to the detriment not only of patients but the economy.

Now that the 2000 agreement has been called invalid, American companies – including Google, Facebook, Apple and Microsoft – can no longer rely on self-certification and must seek to strike "model contract clauses" in each case.

While keeping her invalid mother company, Mrs. Stevens said she used to make pencil holes in the dining-room wall behind her mother's chair, peering at the sawdust and wiring.

But CAFC finds invalid the company's claims on testing for cancer risk by comparing or analyzing DNA sequences because these methods are based on "abstract, mental steps" of logic that are not "transformative".

In Canada "anti-piracy" taxes have raised the price of some iPods by $25 – Canadian courts ruled that such a tax was invalid, the music companies were ordered to return the proceeds to Apple and Apple offered to compensate consumers for the taxes they had paid.

The investigation came a day after a federal judge found that the patents protecting the drug were invalid because the company, Purdue Pharma of Stamford, deliberately misled the United States Patent Office.

And these by and large are patents that were on technology that already existed when the patent was granted or when it was filed, so we think they are all invalid," says the company's general counsel Alan Schoenbaum.

The district asserted that not only was the software late and faulty, the contract with Harris was invalid and the company should pay back $12 million.

The Boston Scientific Corporation has won a court ruling that found a rival patent on stents invalid and allows the company to resume stent sales in the Netherlands.

A federal judge in Wilmington, Del., said a patent owned by Novo was invalid because of the company's errors in the application process, Teva and Savient said in a statement.